You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】恆指重上10天線 石藥先升後跌穿15.4元 恆指牛61551 熊56006/ 石藥最貼牛64075 最貼熊54755/ 美團牛61936 熊51507
阿思達克 04-27 10:30
美國總統特朗普簽署4840億美元抗疫援助法案,另市場觀望新型肺炎治療研究進展以及企業業績,道指上周五收報23775點,升260點(或1.1%),連升三日。全星期計則累跌近2%。恆指上周五收報23831點,跌145點(或0.6%),全周累跌548點(或2.2%)。今早回升逾400點,重上24200點,技術上收復10天線。恆指好倉(牛證及認購權證)上周五淨流出110萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出791萬元,反映投資者於周末前減倉觀望。上周五恆指牛證街貨重貨區為收回價23200至23299點,而熊證街貨重貨區為收回價25000至25099點。

個別中資股於上周五跌幅大於指數。內房股融創(01918)上周五收跌近2%於32.4元,為表現第四差國指成分股。股份自今月上旬見37.45元高位後,呈輾轉向下走勢,先後失守10天和20天線,累挫超過13%。股份今早反彈約1%,上試33元。融創上周五錄逾1.4億元北水淨流出。上周五有73萬元淨流入其好倉,淡倉同日則有19萬元淨流出。

沽壓超大市的還有石藥(01093),股份上周五曾急挫5.4%至15.08元,其後獲買盤支撐,跌幅收窄至2.3%收市,報15.56元,仍是表現第二差的恆指和國指成分股。石藥公布,旗下石藥新諾威首季純利按年增長約29%,石藥今早先升後跌,高位升抵15.8元,其後回至15.4元之下。首個反彈阻力可留意20天線(約16元)。上周五分別有153萬3和30萬元淨流入其好倉和淡倉。

美國證交會警告投資者關注中概股的披露情況和投資風險,加上有券商料疫情為阿里巴巴(09988)帶來短期業績壓力,以及最大股東軟銀潛在減持憂慮重燃,阿里上周五失守200元關口,收跌3.1%報198元,是今月以來首度跌穿10天線。阿里今早回穩,續於200元關前爭持。上周五有逾1400萬元淨流入其好倉,淡倉同日則有8萬元淨流出。

美團(03690)上周五反覆向下,以近全日低位99.2元收市,失百元關及100天線。不過,美團續處二、三月時約96至105元橫行區水平內上落,今月收市亦守10天線之上,走勢未轉弱。今早靠穩,重上「紅底」,其後續於百元關徘徊。上周五有128萬元淨流入其好倉,淡倉同日則有42萬元淨流出。

瑞通相關認股證之選擇:

恆指輕微價外、中年期購25622,行使價:25920點,2020年10月到期,實際槓桿:9倍

石藥價外、中短期購23524,行使價:18.28元,2020年10月到期,實際槓桿:5.4倍

石藥貼價、短期沽28344,行使價:14.68元,2020年7月到期,實際槓桿:5.4倍

融創價外、中年期購23529,行使價:42.23元,2020年12月到期,實際槓桿:4倍

美團輕微價外、中短期購25766,行使價:108.1元,2020年9月到期,實際槓桿:6.3倍

美團輕微價外、中短期沽22255,行使價:88.83元,2020年9月到期,實際槓桿:4.6倍

阿里價外、中年期購23626,行使價:238.8元,2020年11月到期,實際槓桿:6.9倍

阿里貼價、中短期沽22404,行使價:198.88元,2020年10月到期,實際槓桿:3.7倍

紫金價外、中短期購15784,行使價:3.88元,2020年8月到期,實際槓桿:5.6倍

瑞通相關牛熊證之選擇:

恆指牛證61551,收回價:23210點,槓桿比率:21.3倍

恆指熊證56006,收回價:24690點,槓桿比率:31.9倍

石藥牛證64075,收回價:14.4元,槓桿比率:7倍

石藥熊證54755,收回價:19元,槓桿比率:3.2倍

融創牛證58928,收回價:31.4元,槓桿比率:10.3倍

融創熊證62315,收回價:36.4元,槓桿比率:4.8倍

美團牛證61936,收回價:95.6元,槓桿比率:11.5倍

美團熊證51507,收回價:105.1元,槓桿比率:11.8倍

阿里牛證61942,收回價:184.9元,槓桿比率:10倍

阿里熊證54015,收回價:212.9元,槓桿比率:12.7倍

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account